China · Investor

3E Bioventures

Last cheque observed Mar 2026; 30 cheques on record.

VC firmDeploying nowLast fund $147M, Jan 2023

SeedSeries ASeries BHealthHealthcareE-health

Deploying now
8%of best year1cheques in 12 months, 30 on record
Since the last cheque249days00hrs00min00sec
Median round$22MCheque size, as they say$100K – $5.0MRounds led1 of 30Sole investor12 roundsMostly inUnited States, 95%
Pitch 3E Bioventures

3E Bioventures highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series A and Venture: 67% of its rounds

  3. 03

    Sole investor in 12 rounds, median $6.5M

What they do

3E Bioventures Capital is a life science focused VC fund, actively investing in global leading health innovatorsFrom their own website
Type
VC firm (from a list, unverified)
Cheque size
$100K – $5.0M as they say
Stages
SeedSeries ASeries BGrowth
Sectors
HealthHealthcareE-health
Based in
Palo Alto, China
Cold pitches
Accepted

The record

Every round we can evidence, newest first30 appearances

  1. 2026

    1 round

  2. Mar
    Tianhu TechnologySeries A$29MWith 3 others
  3. 2025

    12 rounds

  4. Oct
    SmartlensUS · TechStartups$5.2MWith 5 others
  5. Oct
    OncoC4Series B · US$50MWith 1 other
  6. Sept
    Rapafusyn PharmaceuticalsSeries A · US$16MSole investor
  7. Sept
    CytoNicheVentureUndisclosedWith 3 others
  8. Jul
    Xijian TechnologySeries A$1.4MSole investor
  9. May
    UltraClearSeries B · US$23MSole investor
  10. May
    Sipeng TechnologySeed$1.4MSole investor
  11. May
    Junhemeng BiopharmaceuticalVenture$1.4MWith 1 other
  12. May
    Dermaliq TherapeuticsVenture · USUndisclosedSole investor
  13. Apr
    Novlead BiotechVentureUndisclosedWith 2 others
  14. Mar
    CellbriVentureUndisclosedSole investor
  15. Mar
    Myrobalan TherapeuticsGrant · US$850KSole investor
  16. 2024

    3 rounds

  17. Apr
    Jushu BiotechVentureUndisclosedSole investor
  18. Apr
    Arnatar TherapeuticsSeries A · US$52MWith 3 others
  19. Mar
    varnotechSeries B$83MWith 2 others
  20. 2023

    5 rounds

  21. Sept
    Ligatech BioscienceVentureUndisclosedWith 1 other
  22. Aug
    Eluminex BiosciencesSeries B$10MWith 2 others
  23. May
    Larkspur BiosciencesSeries A · US$36MWith 1 other
  24. May
    CullgenSeries C · US$35MWith 2 others
  25. Jan
    ApexigenUS$2.8MSole investor
  26. 2022

    2 rounds

  27. Nov
    Lipidio PharmaceuticalsSeries A · US$20MSole investor
  28. Aug
    Regenacy PharmaceuticalsSeries B · US$9.3MWith 1 other
  29. 2021

    2 rounds

  30. Aug
    NeuralGalaxySeries A · US$77MWith 3 others
  31. Jan
    Cardea Bio, Inc.Series A · US · Firms' own news pages$6.5MLed
  32. 2018

    3 rounds

  33. Aug
    ProfusaSeries C · US · FinSMEs$45MWith 3 others
  34. May
    AnsunSeries A · US · FinSMEs$85MWith 7 others
  35. May
    Refuge BiotechnologiesSeries B · US · FinSMEs$25MWith 9 others
  36. 2017

    2 rounds

  37. Apr
    EpimABSeries A · CN · FinSMEs$25MWith 1 other
  38. Jan
    OncoImmuneSeries A · US · FinSMEs$15MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration2 named

QKQianye Karen LiuDirector of the General PartneriFiling they signed
YFYu FangDirector of General PartneriFiling they signed

We also hold 7 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as 3E Bioventures. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies 3E Bioventures put money into.

Quick answers about 3E Bioventures

What does 3E Bioventures invest in?

3E Bioventures invests most often at Series A and Venture (67% of the rounds on record), in sectors such as Health, Healthcare and E-health.

How active is 3E Bioventures?

30 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in Mar 2026.

What has 3E Bioventures invested in recently?

Its most recent investments on record: Tianhu Technology (Series A, Mar 2026), Smartlens (Undisclosed round, Oct 2025) and OncoC4 (Series B, Oct 2025).

How big are 3E Bioventures's cheques?

The median round it joins is $22M. It says it writes cheques of $100K to $5.0M.

Does 3E Bioventures lead rounds?

Sometimes: it led 1 of its 30 investments on record (3%).

Where does 3E Bioventures invest?

Most of the companies it backs are in the United States (95%) and China (5%).

Is 3E Bioventures investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

Who does 3E Bioventures invest alongside?

Most often BioVenture (2 rounds together), Gaorong Capital (2 rounds together) and HSG (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it